Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 19, 2019 - Issue 10: Biosimilars
Submit an article Journal homepage
3,051
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Population pharmacokinetics of PF-06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderately to severely active rheumatoid arthritis

Rameshraja PalaparthyClinical Pharmacology, Pfizer Inc, San Diego, CA, USACorrespondence[email protected]
View further author information
,
Muhammad I. RehmanClinical Development, Pfizer Inc, Andover, MA, USAView further author information
,
Oliver von RichterGlobal Clinical Development, Biopharmaceuticals, Sandoz Biopharmaceuticals, Hexal AG (a Sandoz company), Holzkirchen, GermanyView further author information
&
Donghua YinClinical Pharmacology, Pfizer Inc, San Diego, CA, USAView further author information
Pages 1065-1074 | Received 12 Feb 2019, Accepted 20 Jun 2019, Published online: 08 Jul 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.